Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Abbott Laboratories
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Taxation=== {{See also|Double Irish arrangement}} On 19 March 2019, it was reported that Abbott was a long-term user of the [[Double Irish]] tax structure, a legal but controversial Irish taxation tool used by US multinationals to reduce US corporate taxes on non-U.S profits.<ref name="di"/> Abbott's Irish holding company, the Bermuda-resident Abbott Laboratories Vascular Enterprises (ALVE), employed no staff in 2017, but was responsible for distributing Abbot's products and licensing its technology worldwide.<ref name="di"/> Newly filed accounts showed that ALVE was incorporated in 2003 and had a pre-tax profit of €2 billion in 2016 and 2017 on revenues of €5.2 billion; no taxation was paid on these profits.<ref name="di"/> ALVE had never filed accounts in Ireland since 2003 as it was structured as an [[unlimited liability company]] (ULC); however, new EU accounts directives required ALVE to file Irish accounts in 2018.<ref name="di"/> These accounts listed ALVE's registered office as the address of Ireland's largest tax-law firm, [[Matheson (law firm)|Matheson]], who have been identified with Double Irish tax structures for Microsoft and Google.<ref name="di">{{cite news|url=https://www.thejournal.ie/abbott-ireland-tax-avoidance-4528308-Mar2019/|title=How the IDA's top client used Ireland to siphon billions offshore tax-free|newspaper=[[TheJournal.ie]]|author=Peter Bodkin|date=19 March 2019|access-date=19 March 2019|quote=Meanwhile, through a myriad of subsidiaries and system of inter-company charges involving a variation on the infamous so-called 'double Irish' structure, its local operations have also legally shaved their tax bills with the Exchequer despite pulling in huge sales.|archive-date=19 March 2019|archive-url=https://web.archive.org/web/20190319121457/https://www.thejournal.ie/abbott-ireland-tax-avoidance-4528308-Mar2019/|url-status=live}}</ref><ref name="wsj">{{cite news|url=https://www.wsj.com/articles/dublin-moves-to-block-controversial-tax-gambit-1381890312|title=Dublin Moves to Block Controversial Tax Gambit|quote=At least 125 major U.S. companies have registered several hundred subsidiaries or investment funds at 70 Sir John Rogerson's Quay, a seven–story building in Dublin's docklands, according to a review of government and corporate records by The Wall Street Journal. The common thread is the building's primary resident: Matheson, an Irish law firm that specializes in ways companies can use Irish tax law.|newspaper=[[The Wall Street Journal]]|date=15 October 2013|access-date=19 March 2019|author1=Damian Paletta|author2=Kate Linebaugh|archive-date=16 June 2018|archive-url=https://web.archive.org/web/20180616203914/https://www.wsj.com/articles/dublin-moves-to-block-controversial-tax-gambit-1381890312|url-status=live}}</ref> In September 2021, the ''[[Irish Times]]'' reported that Abbott was using the [[Single malt tax|Single Malt]] tax tool to shield profits on its [[COVID-19 testing#Nucleic acid tests|COVID-19 testing kits]].<ref name=abbotlabs>{{cite news | newspaper=[[The Irish Times]] | url=https://www.irishtimes.com/news/health/pharma-giant-abbott-using-irish-single-malt-scheme-to-avoid-tax-on-profits-1.4674126 | title=Pharma giant Abbott using Irish 'single-malt' scheme to avoid tax on profits | first1=Pat | last1=Leahy | date=15 September 2021 | accessdate=16 September 2021 | archive-date=15 September 2021 | archive-url=https://web.archive.org/web/20210915040424/https://www.irishtimes.com/news/health/pharma-giant-abbott-using-irish-single-malt-scheme-to-avoid-tax-on-profits-1.4674126 | url-status=live }}</ref><ref>{{cite news | newspaper=[[The Irish Times]] | first1=Cliff | last1=Taylor | date=15 September 2021 | accessdate=16 September 2021 | url=https://www.irishtimes.com/business/economy/how-abbott-labs-devised-its-formula-for-single-malt-taxation-1.4674058?mode=sample&auth-failed=1&pw-origin=https%3A%2F%2Fwww.irishtimes.com%2Fbusiness%2Feconomy%2Fhow-abbott-labs-devised-its-formula-for-single-malt-taxation-1.4674058 | title=How Abbott Labs devised its formula for 'single Malt' taxation | archive-date=15 September 2021 | archive-url=https://web.archive.org/web/20210915213227/https://www.irishtimes.com/business/economy/how-abbott-labs-devised-its-formula-for-single-malt-taxation-1.4674058?mode=sample&auth-failed=1&pw-origin=https%3A%2F%2Fwww.irishtimes.com%2Fbusiness%2Feconomy%2Fhow-abbott-labs-devised-its-formula-for-single-malt-taxation-1.4674058 | url-status=live }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)